![]() |
|
|
Vol. 288, Issue 2, 522-528, February 1999
Department of Pharmacology, Osaka University of Pharmaceutical
Sciences, Takatsuki, Osaka, Japan
The effects of proadrenomedullin N-terminal 20 peptide (PAMP) on
changes in renal function and norepinephrine (NE) overflow induced by
renal nerve stimulation (RNS) were examined in anesthetized dogs. The
intrarenal arterial infusion of PAMP (10, 50, 100 ng/kg/min) did not
influence basal levels of systemic and renal hemodynamics, or urine
formation. RNS at a low frequency (0.5-2.0 Hz) caused significant
decreases in urine flow and urinary excretion of sodium, and increases
in NE secretion rate (NESR), without affecting renal hemodynamics. RNS
at a high frequency (2.5-5.0 Hz), which diminishes renal hemodynamics,
elicited more potent decreases in urine formation and increases in
NESR. The low frequency RNS-induced reductions in urine formation and
increases in NESR were almost completely abolished by the intrarenal
arterial infusion of PAMP at 50 ng/kg/min, a dose that produced no
alterations on basal renal hemodynamics and excretory responses. In
contrast, high frequency RNS-induced renal vasoconstriction and
reductions in urine formation, and increases in NESR were not affected
by infusion of the peptide. We next examined the effect of PAMP on
exogenously applied NE-induced renal actions, to determine if PAMP
functions suppressively at postjunctional sites. The intrarenal
arterial infusion of NE (100-150 ng/kg/min) produced a significant
renal vasoconstriction and a reduction in urine formation, responses
not affected by the administration of PAMP (50 ng/kg/min). From these
findings, we suggest that PAMP functions as an inhibitory modulator of
renal noradrenergic neurotransmission, via prejunctional mechanisms,
and plays an important role in regulating renal functions.
This article has been cited by other articles:
![]() |
T. Yamasaki, I. Tamai, and Y. Matsumura Activation of histamine H3 receptors inhibits renal noradrenergic neurotransmission in anesthetized dogs Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2001; 280(5): R1450 - R1456. [Abstract] [Full Text] [PDF] |
||||